Safety and eficity of 2.5mg prasugrel therapy in the eldely or low body weight Japanese patients undergoing percutaneous coronary intervention
Phase of Trial: Phase IV
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Prasugrel (Primary)
- Indications Ischaemic heart disorders
- Focus Therapeutic Use
- 15 Nov 2017 Status changed from recruiting to completed.
- 27 May 2016 Status changed from not yet recruiting to recruiting.
- 27 Oct 2015 New trial record